- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
- You can view the full Merck Ratings Report.
Here are the winning banks.
Bristol-Myers Squibb stock has fallen by 35% in the last six months.
Doug Kass shares his thoughts on biotech and discusses the shape of things to come.